← Back to Search

Behavioral Intervention

OUD intervention for Opioid Use Disorder

N/A

Recruiting

Led By Susan L Calcaterra, MD

Research Sponsored by University of Colorado, Denver

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up calculate mean monthly cows scores over a three year time frame (including pre and post implementation) to assess for change

Awards & highlights

Study Summary

"This trial introduced a new treatment program for opioid use disorder in 12 hospitals in Colorado to help adults with opioid use disorder who are hospitalized."

Who is the study for?

This trial is for hospitalized adults in Colorado who are diagnosed with Opioid Use Disorder (OUD) and are experiencing a gap in treatment. Specific eligibility criteria details were not provided, so it's important to contact the study organizers for more information.Check my eligibility

What is being tested?

The trial is testing an intervention designed to improve OUD treatment among hospitalized patients across 12 hospitals. It aims to address the current shortcomings in care for individuals suffering from opioid addiction.See study design

What are the potential side effects?

Since specific interventions and their side effects aren't detailed, potential participants should ask the research team about what treatments are involved and any associated risks or side effects.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ calculate monthly prescribing rates over a three year time frame (including pre and post implementation) to assess for change

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~calculate monthly prescribing rates over a three year time frame (including pre and post implementation) to assess for change

This trial's timeline: 3 weeks for screening, Varies for treatment, and calculate monthly prescribing rates over a three year time frame (including pre and post implementation) to assess for change for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in buprenorphine prescribing at hospital discharge

Secondary outcome measures

Change in rates of methadone prescribing during hospitalization

Other outcome measures

Change in average (mean) COWS score over time

Change in naloxone prescribing at hospital discharge

Trial Design

1Treatment groups

Experimental Treatment

Group I: OUD interventionExperimental Treatment1 Intervention

Participants received education on the diagnosis and management of OUD, have access to protocols to walk them through assessment of OUD using Diagnostic and Statistical Manual, fifth Edition (DSM)-5, COWS score to calculate severity of opioid withdrawal, buprenorphine or methadone initiation with pre-populated orders, and clickable links for OUD treatment referral post discharge.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

National Institute on Drug Abuse (NIDA)NIH

2,470 Previous Clinical Trials

2,619,331 Total Patients Enrolled

University of Colorado, DenverLead Sponsor

1,738 Previous Clinical Trials

2,149,126 Total Patients Enrolled

Susan L Calcaterra, MDPrincipal InvestigatorUniversity of Colorado, Denver

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Do I meet the requirements to participate in this clinical study?

"Candidates must have opioid use disorder and be between 18 and 99 years old to qualify for participation in this investigation. Enrollment is anticipated to reach approximately 400 individuals."

Answered by AI

Are potential participants currently able to join this research study?

"Affirmative. Information on clinicaltrials.gov confirms that patient recruitment is ongoing for this investigation. It was initially posted on January 18, 2023, and last updated on February 26, 2024. Enrollment of approximately 400 participants is sought from a single designated site."

Answered by AI

What is the current cumulative count of individuals participating in this clinical investigation?

"Affirmative, data sourced from clinicaltrials.gov denotes that this trial is actively in search of suitable candidates. The study was initially posted on January 18th, 2023 and last revised on February 26th, 2024. Enrollment aims to reach a total of 400 patients at one designated site."

Answered by AI

Can individuals older than 40 years partake in this research study?

"Participants eligible for this research study must be aged between 18 and 99 years old. It's worth noting that there are a significant number of studies available for individuals under 18 (90 studies) and those over 65 (394 studies)."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

A Multi-site Intervention to Expand Hospital Based OUD Treatment Provision

Susan L. Calcaterra, MD, MPH 2023. "A Multi-site Intervention to Expand Hospital Based OUD Treatment Provision". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06291090.

All > Vision > Colorado Springs